Kobayashi Pharmaceutical is the parent company of a group mainly engaged in the manufacture and sale of deodorizing air fresheners, pharmaceuticals, oral hygiene products and other products, as well as the import and market of medical devices for use in medical. Co.'s principal business segments are domestic consumer products business, overseas consumer products business, and mail-order business. Co.'s principal products are pharmaceuticals, oral hygiene products, sanitary products, deodorizing air fresheners, household sundries, food products, body warmers, and others. Co. also provides food products and skincare products, collagen, face cream and hair tonic with aloe through mail order.
Ford US Equity Research covers more than 4,000 stocks using a proprietary quantitative model that evaluates a company’s earnings strength, its relative valuation and recent price movement. Ford’s five recommendation ratings include strong buy, buy, hold, sell, strong sell. For all stocks in our coverage universe, ratings are generated each week and reflect the fundamental and price data as of the last trading day of the week.
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.